The New England journal of medicine
-
Letter Randomized Controlled Trial
N-of-1 Trial of a Statin, Placebo, or No Treatment to Assess Side Effects.
-
Randomized Controlled Trial Multicenter Study Comparative Study
Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve.
The effects of rivaroxaban in patients with atrial fibrillation and a bioprosthetic mitral valve remain uncertain. ⋯ In patients with atrial fibrillation and a bioprosthetic mitral valve, rivaroxaban was noninferior to warfarin with respect to the mean time until the primary outcome of death, major cardiovascular events, or major bleeding at 12 months. (Funded by PROADI-SUS and Bayer; RIVER ClinicalTrials.gov number, NCT02303795.).